file1,
file2, etc. all in the same folder or directory;
first, locate one of the files with the [Browse...] button. Then alter the
file path in the box above to include '*' character (eg. file*).
Wildcard '?' to blanket only one character works too.| Historiographs |
Grand Totals: LCS 1825, GCS 236997, CR 107598 Collection span: 1983 - 2009 | |
| Word(i) List (1171) Word count: 3958, All words count: 5896 | ||
| # | Word | Recs | TLCS | TGCS |
|---|---|---|---|---|
| 801 | COLLAGEN | 1 | 2 | 156 |
| 802 | TARGETING | 1 | 2 | 156 |
| 803 | INFORMATION | 1 | 2 | 155 |
| 804 | ORCHESTRATED | 1 | 2 | 155 |
| 805 | UNDERLYING | 1 | 2 | 155 |
| 806 | INTEGRATION | 1 | 1 | 154 |
| 807 | CD22 | 1 | 1 | 153 |
| 808 | THETA | 1 | 0 | 153 |
| 809 | AUTOPATHOGENIC | 1 | 1 | 152 |
| 810 | DISTINCT | 1 | 4 | 152 |
| 811 | EAE | 1 | 1 | 152 |
| 812 | FUNCTIONALLY | 1 | 4 | 152 |
| 813 | PROSPECTS | 2 | 0 | 152 |
| 814 | SHAPING | 1 | 1 | 152 |
| 815 | TUNING | 1 | 1 | 152 |
| 816 | ENDOGENOUS | 2 | 0 | 151 |
| 817 | FEATURES | 1 | 1 | 151 |
| 818 | LEPROSY | 1 | 3 | 151 |
| 819 | OBSERVATIONS | 1 | 3 | 151 |
| 820 | STIGMA | 1 | 3 | 151 |
| 821 | VARIATIONS | 1 | 3 | 151 |
| 822 | EPITHELIUM | 1 | 0 | 150 |
| 823 | IL4 | 1 | 0 | 150 |
| 824 | CHEMISTRY | 1 | 0 | 149 |
| 825 | MARGINAL | 2 | 2 | 149 |
| 826 | ZONE | 2 | 2 | 149 |
| 827 | NETWORKS | 1 | 2 | 148 |
| 828 | DISCRIMINATION | 1 | 1 | 147 |
| 829 | EATON | 1 | 1 | 147 |
| 830 | GRAVIS | 1 | 1 | 147 |
| # | Word | Recs | TLCS | TGCS |
| 831 | LAMBERT | 1 | 1 | 147 |
| 832 | MYASTHENIA | 1 | 1 | 147 |
| 833 | SOLUTIONS | 1 | 1 | 147 |
| 834 | AGE | 1 | 1 | 146 |
| 835 | DETERMINE | 1 | 3 | 145 |
| 836 | PLASMA | 1 | 3 | 145 |
| 837 | INDUCE | 1 | 1 | 144 |
| 838 | EOSINOPHILS | 1 | 1 | 143 |
| 839 | CATERPILLER | 1 | 1 | 142 |
| 840 | IMPORTANT | 1 | 1 | 142 |
| 841 | TARGETS | 2 | 1 | 142 |
| 842 | EPITOPES | 1 | 4 | 141 |
| 843 | INVITRO | 2 | 3 | 141 |
| 844 | FETAL | 1 | 1 | 140 |
| 845 | MATERNAL | 1 | 1 | 140 |
| 846 | SUPPRESSION | 1 | 1 | 140 |
| 847 | HEALTH | 1 | 2 | 139 |
| 848 | IMMUNODEFICIENCIES | 2 | 2 | 139 |
| 849 | PHOSPHOINOSITIDE | 1 | 1 | 139 |
| 850 | CROSSROADS | 1 | 0 | 138 |
| 851 | DEPOSITION | 1 | 0 | 138 |
| 852 | FEMALE | 1 | 0 | 138 |
| 853 | FERTILITY | 1 | 0 | 138 |
| 854 | LYMPHOCYTIC | 1 | 0 | 138 |
| 855 | MATRIX | 1 | 0 | 138 |
| 856 | PENTRAXINS | 1 | 0 | 138 |
| 857 | BIOSYNTHESIS | 2 | 6 | 137 |
| 858 | XENOPUS | 1 | 0 | 137 |
| 859 | CHARACTERIZING | 1 | 0 | 136 |
| 860 | IGA | 1 | 0 | 136 |
| # | Word | Recs | TLCS | TGCS |
| 861 | IMMUNOSUPPRESSION | 1 | 0 | 136 |
| 862 | PERTURB | 1 | 0 | 136 |
| 863 | SELECTED | 1 | 0 | 136 |
| 864 | CHIPS | 1 | 1 | 135 |
| 865 | NATURE | 1 | 1 | 135 |
| 866 | IDIOTYPIC | 1 | 0 | 131 |
| 867 | ISLET | 1 | 0 | 131 |
| 868 | MAMMARY | 1 | 2 | 131 |
| 869 | MIMICRY | 1 | 0 | 131 |
| 870 | OXIDANT | 1 | 1 | 131 |
| 871 | REFERENCE | 1 | 1 | 131 |
| 872 | SPECIAL | 1 | 1 | 131 |
| 873 | 1ST | 2 | 1 | 128 |
| 874 | ALLERGENS | 1 | 0 | 127 |
| 875 | COMMUNICATIONS | 1 | 1 | 127 |
| 876 | IKAROS | 1 | 6 | 127 |
| 877 | LIGHT | 1 | 1 | 127 |
| 878 | LYMPHOTOXINS | 1 | 1 | 127 |
| 879 | RESPONSIVENESS | 1 | 0 | 127 |
| 880 | UNIQUE | 3 | 2 | 127 |
| 881 | YEARS | 2 | 1 | 127 |
| 882 | C3D | 1 | 2 | 126 |
| 883 | FRAGMENT | 1 | 2 | 126 |
| 884 | ALDRICH | 1 | 3 | 125 |
| 885 | CONTROLLING | 1 | 0 | 125 |
| 886 | CYCLE | 1 | 0 | 125 |
| 887 | CYTOSKELETAL | 1 | 3 | 125 |
| 888 | WASP | 1 | 3 | 125 |
| 889 | WISKOTT | 1 | 3 | 125 |
| 890 | ABL | 1 | 1 | 124 |
| # | Word | Recs | TLCS | TGCS |
| 891 | BACK | 1 | 1 | 124 |
| 892 | BCR | 1 | 1 | 124 |
| 893 | BEDSIDE | 1 | 1 | 124 |
| 894 | BENCH | 1 | 1 | 124 |
| 895 | LIPOXYGENASE | 1 | 1 | 124 |
| 896 | MEDICINE | 1 | 1 | 124 |
| 897 | PRODUCED | 1 | 1 | 124 |
| 898 | SCIENCE | 1 | 1 | 124 |
| 899 | SMALL | 1 | 0 | 124 |
| 900 | STORY | 1 | 1 | 124 |
| 901 | TRANSACTIVATION | 1 | 1 | 124 |
| 902 | COMPARTMENTALIZED | 1 | 0 | 123 |
| 903 | MAPK | 1 | 0 | 123 |
| 904 | RAS | 1 | 0 | 123 |
| 905 | BALANCE | 2 | 1 | 122 |
| 906 | COMBINED | 1 | 2 | 122 |
| 907 | DEFECTS | 1 | 2 | 122 |
| 908 | IMMUNORECEPTOR | 1 | 0 | 122 |
| 909 | SEVERE | 1 | 2 | 122 |
| 910 | HUMANS | 2 | 0 | 121 |
| 911 | DETERMINED | 1 | 4 | 120 |
| 912 | GENETICALLY | 1 | 4 | 120 |
| 913 | ENCODED | 1 | 2 | 117 |
| 914 | HELICOBACTER | 1 | 0 | 117 |
| 915 | PYLORI | 1 | 0 | 117 |
| 916 | VIEWS | 1 | 0 | 116 |
| 917 | ADDRESS | 1 | 0 | 115 |
| 918 | VASCULATURE | 1 | 0 | 115 |
| 919 | CORECEPTOR | 1 | 0 | 114 |
| 920 | ANTAGONISM | 1 | 1 | 112 |
| # | Word | Recs | TLCS | TGCS |
| 921 | ARTIFICIAL | 1 | 1 | 112 |
| 922 | LEVELS | 1 | 1 | 112 |
| 923 | ONTOGENY | 2 | 1 | 112 |
| 924 | SERUM | 1 | 1 | 112 |
| 925 | VACCINATIONS | 1 | 1 | 112 |
| 926 | LIGASES | 1 | 0 | 111 |
| 927 | UBIQUITIN | 1 | 0 | 111 |
| 928 | VIEW | 3 | 0 | 110 |
| 929 | PROGRESSIVE | 1 | 1 | 109 |
| 930 | HEURISTIC | 1 | 0 | 108 |
| 931 | SCHISTOSOMES | 1 | 0 | 108 |
| 932 | CTL | 1 | 1 | 106 |
| 933 | DRUG | 1 | 0 | 106 |
| 934 | ARTHRITIDES | 1 | 1 | 105 |
| 935 | AVIAN | 1 | 0 | 103 |
| 936 | CHROMATIN | 1 | 2 | 103 |
| 937 | CONVERSION | 1 | 0 | 103 |
| 938 | DEVELOPING | 1 | 0 | 102 |
| 939 | STAGE | 1 | 0 | 102 |
| 940 | CONDITIONING | 1 | 0 | 100 |
| 941 | PHASE | 1 | 0 | 100 |
| 942 | PRORESOLVING | 1 | 0 | 100 |
| 943 | RESOLUTION | 1 | 0 | 100 |
| 944 | SIGNIFICANCE | 1 | 2 | 100 |
| 945 | TSLP | 1 | 0 | 100 |
| 946 | IGH | 1 | 1 | 98 |
| 947 | SURROGATE | 1 | 1 | 98 |
| 948 | RETROVIRUSES | 2 | 1 | 95 |
| 949 | APPROACH | 1 | 2 | 94 |
| 950 | CHAINS | 1 | 3 | 94 |
| # | Word | Recs | TLCS | TGCS |
| 951 | CIRCUMSPOROZOITE | 1 | 2 | 94 |
| 952 | INBRED | 1 | 3 | 94 |
| 953 | LAMBDA | 1 | 3 | 94 |
| 954 | CHARACTERISTICS | 1 | 3 | 91 |
| 955 | CLINIC | 1 | 0 | 91 |
| 956 | GRANULOMATOUS | 1 | 1 | 91 |
| 957 | HEAVY | 1 | 0 | 91 |
| 958 | LYME | 1 | 0 | 90 |
| 959 | REVIEW | 1 | 0 | 90 |
| 960 | OCCURRING | 1 | 0 | 89 |
| 961 | NONCLASSICAL | 1 | 3 | 88 |
| 962 | IMMUNOPATHOLOGY | 1 | 0 | 87 |
| 963 | FRIEND | 1 | 0 | 86 |
| 964 | RETROVIRUS | 1 | 0 | 86 |
| 965 | SPONTANEOUS | 1 | 0 | 86 |
| 966 | CLONING | 1 | 1 | 84 |
| 967 | DEFICIENT | 1 | 1 | 84 |
| 968 | DETERMINATION | 1 | 1 | 84 |
| 969 | GLYCOSYLATION | 1 | 0 | 84 |
| 970 | HISTORY | 1 | 1 | 84 |
| 971 | IMPACT | 1 | 0 | 84 |
| 972 | MALE | 1 | 1 | 84 |
| 973 | NEOPLASIA | 1 | 0 | 84 |
| 974 | SEX | 1 | 1 | 84 |
| 975 | ACTIVE | 1 | 0 | 81 |
| 976 | IMMUNOLOGICALLY | 1 | 0 | 81 |
| 977 | INTEGRINS | 1 | 2 | 81 |
| 978 | MINOR | 1 | 2 | 81 |
| 979 | MLS | 1 | 2 | 81 |
| 980 | QUESTION | 1 | 0 | 81 |
| # | Word | Recs | TLCS | TGCS |
| 981 | FATE | 1 | 0 | 80 |
| 982 | INTERPLAY | 1 | 0 | 80 |
| 983 | METABOLISM | 1 | 0 | 80 |
| 984 | OSTEOIMMUNOLOGY | 1 | 0 | 80 |
| 985 | COLONY | 1 | 0 | 79 |
| 986 | USE | 1 | 0 | 79 |
| 987 | BASED | 1 | 0 | 76 |
| 988 | CORRESPONDING | 1 | 0 | 76 |
| 989 | EMERGENCE | 1 | 0 | 76 |
| 990 | TEC | 1 | 3 | 76 |
| 991 | RATIONAL | 1 | 1 | 73 |
| 992 | CORRELATES | 1 | 1 | 72 |
| 993 | DIVERSIFICATION | 1 | 0 | 72 |
| 994 | IDIOTOPES | 1 | 1 | 72 |
| 995 | MYELOID | 1 | 0 | 72 |
| 996 | PHAGOCYTE | 1 | 0 | 72 |
| 997 | RABBIT | 1 | 1 | 72 |
| 998 | USAGE | 1 | 1 | 72 |
| 999 | FULL | 1 | 2 | 71 |
| 1000 | SERVICE | 1 | 2 | 71 |